Literature DB >> 7205448

Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease.

W F Balistreri, F J Suchy, M K Farrell, J E Heubi.   

Abstract

Serum levels of the primary bile acids cholic and chenodeoxycholic acid are transiently elevated in normal neonates and infants; this represents a state of "physiologic cholestasis." In this study we determined, using specific radioimmunoassay, the concentration of a secondary bile acid, sulfated lithocholate, in serum obtained from healthy infants and from those with various hepatobiliary diseases. The serum levels of sulfated lithocholate were low in 69 neonates (less than 5 days of age: mean +/- SEM = 0.45 +/- 0.05 mumoles/L) and in 78 normal infants (less than one year of age: 0.49 +/- 0.02); there was no postprandial rise. These values were similar to those seen in 95 older children (0.56 +/- 0.03) and in maternal (0.49 +/- 0.04) and cord blood (0.44 +/- 0.03) of the neonates. In contrast, in patients with neonatal cholestasis of any nature there was a consistent marked rise in serum concentrations of sulfated lithocholate (mean = 4.46 +/- 0.39, P less than 0.001). In infants monitored during the course of parenteral nutrition, elevated values of sulfated lithocholate often occurred in the presence of normal results of other liver function tests. Serum sulfated lithocholate concentration is an accurate index of neonatal hepatobiliary disease; the sensitivity and specificity of this test remain to be further defined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205448     DOI: 10.1016/s0022-3476(81)80702-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Fetal and neonatal bile acid synthesis and metabolism--clinical implications.

Authors:  W F Balistreri
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Inhibition of glutathione-conjugate secretion from isolated hepatocytes by dipolar bile acids and other organic anions.

Authors:  R P Oude Elferink; R Ottenhoff; A Radominska; A F Hofmann; F Kuipers; P L Jansen
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 3.  Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks.

Authors:  Eric I Benchimol; Catharine M Walsh; Simon C Ling
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

4.  Hepatobiliary effects of cholic and lithocholic acids: experimental study in hamsters.

Authors:  Ivonete Siviero; Saulo M R Ferrante; Ivens Baker Meio; Kalil Madi; Vera L Chagas
Journal:  Pediatr Surg Int       Date:  2007-11-17       Impact factor: 1.827

5.  Lithocholate glucuronide is a cholestatic agent.

Authors:  D G Oelberg; M V Chari; J M Little; E W Adcock; R Lester
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 6.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

7.  Biochemical diagnosis of liver disease.

Authors:  P L Wolf
Journal:  Indian J Clin Biochem       Date:  1999-01

8.  Clinical and molecular characterization of four patients with NTCP deficiency from two unrelated families harboring the novel SLC10A1 variant c.595A>C (p.Ser199Arg).

Authors:  Hua Li; Mei Deng; Li Guo; Jian-Wu Qiu; Gui-Zhi Lin; Xiao-Ling Long; Xiao-Min Xiao; Yuan-Zong Song
Journal:  Mol Med Rep       Date:  2019-10-23       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.